2,000
Participants
Start Date
September 22, 2022
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
No intervention
As per widely adopted clinical research practice for case reviews of de-identified, anonymised data, no explicit consent of participants (or their legal guardians) would be required for this study other than the consent they provided at biopsy (from which the whole genome sequencing data is derived) for researchers to access their notes (as documented on hospital consent form).
Wellcome Sanger Institute, Cambridge
The Wellcome Sanger Institute
OTHER